CytoMed Therapeutics' Chairman Increases Effective Holdings to 21.95% GlobeNewswire October 22, 2025 SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, […]

Rezolve Ai Strengthens Leadership Team to Accelerate Global Growth, Operational Scale, and AI Innovation New structure positions Rezolve AI for sustained profitability, global expansion, and execution at scale GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions and a partner of

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development GlobeNewswire October 22, 2025 Nasir Khan, DVM, Ph.D.: Senior Vice President of Preclinical DevelopmentGary Ingenito, MD, Ph.D.: Senior Vice President of Clinical Development WALTHAM, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) — Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative

Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET GlobeNewswire October 22, 2025 BRISBANE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement GlobeNewswire October 22, 2025 MELBOURNE, Australia and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, today announced that it has received an additional 180-calendar-day

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis GlobeNewswire October 22, 2025 LA JOLLA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology

Axonius Advances Cybersecurity's Most Trusted Asset Intelligence Platform, Announcing New AI Automation and Exposure Management Capabilities GlobeNewswire October 22, 2025 New Axonius AI moves organizations from passive assessment to automated recommendations and response, closing the critical “actionability gap” New advancements in the Axonius Asset Cloud deliver deeper intelligence across all assets, from cloud instances to

SONORO GOLD ANNOUNCES CLOSING OF OVERSUBSCRIBED $4 MILLION PRIVATE PLACEMENT GlobeNewswire October 22, 2025 VANCOUVER, Canada, Oct. 22, 2025 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed its previously announced oversubscribed, non-brokered private placement of 20,500,000 units

Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor(R) Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach GlobeNewswire October 22, 2025 WESTBROOK, Maine, Oct. 22, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a series of major retail authorizations and distribution partnerships across

Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report Company earns “Best” ranking in Arizona, California, Nevada, North Carolina and Texas, reflecting strong performance in care quality, prevention and satisfaction GlobeNewswire October 22, 2025 ORANGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) —